MYC and neoplasm: One example of those is MYCi975, which, in preclinical studies, induced MYC degradation, impaired MYC-mediated gene expression, and suppressed tumor growth.410,411 Furthermore, akin to approaches for other previously deemed “undruggable” proteins, degrader technologies such as PROTACS are also being explored for MYC.